The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgene.
Gene therapy of genetic diseases requires persistent and position-independent expression of a therapeutic transgene. Transcriptional enhancers binding chromatin-remodeling and modifying complexes may play a role in shielding transgenes from repressive chromatin effects. We tested the activity of the...
Main Authors: | Annarita Miccio, Valentina Poletti, Francesca Tiboni, Claudia Rossi, Antonella Antonelli, Fulvio Mavilio, Giuliana Ferrari |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3229501?pdf=render |
Similar Items
-
Analysis of the human alpha globin upstream regulatory element (HS-40) in transgenic mice.
by: Sharpe, J, et al.
Published: (1992) -
Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2.
by: Anguita, E, et al.
Published: (2004) -
Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
by: Letizia Fontana, et al.
Published: (2023-02-01) -
Regulation of Gata1 Expression by HS+3 5
by: Draper, J, et al.
Published: (2010) -
Regulation of Gata1 Expression by HS+3.5
by: Draper, J, et al.
Published: (2010)